Spravato (esketamine) is a prescription drug that’s approved to treat certain forms of depression. Esketamine comes as a nasal spray that you inhale. Specifically, Spravato is approved by the ...

In the ESCAPE-TRD study, Spravato outperformed quetiapine on the main endpoint of achieving remission at eight weeks, measured by the Montgomery-Åsberg Depression Rating Scale (MADRS), with rates ...

Spravato (esketamine) was approved by the EMA in December as an adjunctive, add-on therapy for people with serious depression who don’t respond to treatment with at least two from the current ...

But Behrens adds that ketamine has been the No. 1 medication studied in depression over the past ... infusion therapy or prescription nasal spray Spravato at PAX. But ketamine works best while ...

Active Path Mental Health is proud to announce its expanded Transcranial Magnetic Stimulation (TMS) services for adolescents , offering a safe, non-invasive, and FDA-cleared treatment option for teens ...

He completed a fellowship in Interventional Neuropsychiatry and Neuromodulation at Massachusetts General Hospital, bringing extensive expertise to the management of treatment-resistant mental health ...

Stigma surrounding mental health remains one of the biggest barriers to seeking care, and for many individuals, that stigma ...

Operating expenses during the first quarter of 2025 were $26.8 million, an increase of $6.9 million, or 35%, compared to $19.9 million in the first quarter of 2024, mainly attributable to inclusion of ...

Q1 2025 Earnings Conference Call May 8, 2025 8:00 AM ET. Company Participants. Stephanie Fagan - Chief Corporate Affairs Officer Rob Bar ...

"Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium do Kalkine que laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis ...

A leading mental health clinic in Atlanta has expanded its psychiatry services, making it easier for residents to find a ...

This FDA-approved therapy is now available to patients suffering from treatment-resistant depression (TRD), offering a promising new path for those who have not responded to traditional ...